Med BioGene Inc.

Med BioGene Inc.
Stock Exchange Toronto Ventures Stock Exchange
EPS
CAD0.01
Market Cap
CAD702.67 K
Shares Outstanding
13.26 M
Public Float
7.72 M

Profile

Address
598 East Kent Avenue South
Vancouver British Columbia V5X 4V6
Canada
Employees -
Website http://www.medbiogene.com
Updated 07/08/2019
Med BioGene, Inc. operates as a life science company, which engages in the development and commercialization of genomic-based clinical laboratory diagnostic tests. It focuses on managing the license and rights for GeneFx Lung, prognostic genomic-based test for non-small-cell lung cancer. The company was founded on April 28, 2006 and is headquartered in Vancouver, Canada.

Financials

View All

Iain Weir-Jones
Chairman & Chief Executive Officer
Terence W. Friedlander
Independent Director